Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

MedPharma to raise L8.8 million in year's first IPO.
April 28, 2003

World's third-largest company begins trading after mega-merger.
April 28, 2003

Crucell narrows losses in 1st-quarter, revenues flat.
April 28, 2003

Merck KGaA and GSK drop antidepressant.
April 28, 2003

DTB finds no evidence of autism with MMR.
April 28, 2003

Almirall licenses triptan to Ortho-McNeil.
April 28, 2003

Aventis' Arava licensed in Japan for RA.
April 28, 2003

Fournier to co-market repaglinide in Europe.
April 28, 2003

Israel's health reforms: a "basket" case, a road map and a heavyweight...
April 28, 2003

Europe goes on-line for health info, but still prefers traditional sou...
April 28, 2003

Estonia won't subsidize Glivec.
April 28, 2003

Good prospects for Belarus drug industry.
April 28, 2003

Red tape delays AIDS grant to South Africa.
April 28, 2003

"Bleak future for Australian biotech".
April 28, 2003

Dispensing doctors to challenge SA law.
April 28, 2003

Iran/France drug JV.
April 28, 2003

Renagel sales boost Genzyme in 1st-qtr.
April 28, 2003

Rituxan deal drives IDEC revenues higher.
April 28, 2003

Ribozyme rebrands to Sirna Therapeutics.
April 28, 2003

Galen completes Pfizer product acquisitions.
April 28, 2003

Aurobindo launches new antibiotic in India.
April 28, 2003

GSK settles Paxil lawsuit with Par Pharma.
April 28, 2003

CytRx makes bid for position in RNAi tech.
April 28, 2003

New Zocor 40mg label cites HPS data.
April 28, 2003

Medicis gets US OK for Dynacin tablets for acne.
April 28, 2003

HGS lupus drug gets fast-tracked by FDA.
April 28, 2003

Lorus expands Virulizin Phase III trial.
April 28, 2003

GSK seeks OK for new topotecan studies.
April 28, 2003

Elite allergy drug clears Phase I trial.
April 28, 2003

RegeneRx starts enrollment in wound trial.
April 28, 2003

SBI cleared to start blood substitute trials.
April 28, 2003

Revenues up at Merck & Co on key drug sales, profits hit by increased ...
April 28, 2003

Biogen's 1st-qtr profit down, underlying growth edges up on Avonex sal...
April 28, 2003

Hassan takes biggest pay rise in 2002 CEO compensation.
April 28, 2003

Aventis reiterates full-year sales and earnings forecast.
April 28, 2003

Aphton opts against renewal of licensing deal with Aventis.
April 28, 2003

Zimbabwe's Datlabs struggling to raise funds to upgrade facilities.
April 28, 2003

Profits up at Australia's Sigma on Wyeth brand sales.
April 28, 2003

Sagres acquires MemRx, enhances discovery programs.
April 28, 2003

US states "failing to monitor effects of Rx prior authorization under ...
April 28, 2003

Takeda forecasts 315B yen profit in 2004.
April 28, 2003

Fujisawa to write off investment losses.
April 28, 2003

Poor 1st qtr for GSK Consumer in India.
April 28, 2003

Achillion and Phytobiotech in drug discovery alliance.
April 28, 2003

Isis gets milestone in Lilly collaboration.
April 28, 2003

Able says first to ship Lithobid generic in USA.
April 28, 2003

Microscience plans trials of oral anthrax vaccine in '04.
April 28, 2003

Diatos licenses Medarex cancer drug in Europe.
April 28, 2003

BCG may cut asthma; study.
April 28, 2003

Advance in malaria treatment?
April 28, 2003

Kaken develops soluble drug technology.
April 28, 2003

Doblique to buy INyX Pharma.
April 28, 2003

NeoRx gains $10M for IP assignment to Boston Scientific.
April 28, 2003

Dendrite to acquire Synavant.
April 28, 2003

GlycoDesign announces restructuring.
April 28, 2003

US views of Rx imports swayed by health fears.
April 28, 2003

US FDA to withdraw outdated draft props.
April 28, 2003

US OPM to expand oversight of PBMs.
April 28, 2003

US MCO pharmacy guide to drug pricing.
April 28, 2003

PhRMA pledge to FDA over counterfeit drugs.
April 28, 2003

J-TE develops system for regenerative medicine.
April 28, 2003

FDA OK for Bayer Biological facility.
April 28, 2003

LION Bioscience expands in Italy.
April 28, 2003

Pfizer boosted by disposals in 1st-qtr, double-digit sales and EPS gro...
April 28, 2003

Amersham Health to merge with Galil.
April 28, 2003

Akzo Nobel 1st qtr earnings plunge 30%.
April 28, 2003

GSK in more talks on Montrose plant.
April 28, 2003

Italy's Chiesi sees flat sales in 2002.
April 28, 2003

AstraZeneca rations drug supplies to Canadian pharmacies.
April 28, 2003

Allos Therapeutics' brain cancer trial misses primary endpoint.
April 28, 2003

Amgen set to file for cinacalcet in 2003.
April 28, 2003

Indevus buys antifungal drug from Aventis.
April 28, 2003

S Africa govt pledge for HIV/AIDS.
April 28, 2003

S African Rx price panel plan is extremist and against free trade, say...
April 28, 2003

Japan ban on drug ads "could be lifted".
April 28, 2003

Page 1|2|3|4|5|6